Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu realizuje projekt „Comparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis – the head to head COMBO-UC trial”.
Pfizer Global Medical Grants Announces a New Research RFP in Nonalcoholic Steatohepatitis (NASH)